This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biogen Inc (BIIB)

NASDAQ: Health Care

Company Profile
Price and Volume
Recent Price 279.24
52 Week High 480.18
52 Week Low 265.00
Avg. Daily Vol. (Mil) 2.98
Beta (3 year) 0.63
Share Related Items
Mkt Cap (Mil) 65,668.65
Shares Out (Mil) 235.17
Float (Mil) 234.98
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.60
Current Ratio 2.20
LT Debt/ Equity 0.05
Total Debt / Equity 0.05
Valuation Ratios
Price Earnings 18.90
Price/Sales 7.27
Price/Book 5.22
Price/Cash Flow 16.00
Per Share Data
Earnings 14.78
Sales 38.42
Book Value 53.46
Cash Flow 17.47
Business Summary
Biogen Idec Inc, is a biopharmaceutical company. The Company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.
General Information
225 Binney Street
Cambridge, MA 02142
Industry : Drugs
Sector: Health Care
Employees: 7550
CEO: Dr. George A. Scangos,Ph
Short Interest
Current Month (Mil) 4.59
Previous Month (Mil) 3.86
Short Interest Ratio (Days) 2.00
Management Effectiveness
Return on Equity 27.70
Return on Assets 20.80
Return on Investments 26.50
Gross Margin 89.00
EBIT Margin 51.40
Profit Margin 38.60

Analysts Ratings for BIIB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 11 10 10
Moderate Buy 2 2 2 2
Hold 8 9 9 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

BIIB Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs